[go: up one dir, main page]

FI953794L - N-Alkyyli-2-substituoidut ATP-analogit - Google Patents

N-Alkyyli-2-substituoidut ATP-analogit Download PDF

Info

Publication number
FI953794L
FI953794L FI953794A FI953794A FI953794L FI 953794 L FI953794 L FI 953794L FI 953794 A FI953794 A FI 953794A FI 953794 A FI953794 A FI 953794A FI 953794 L FI953794 L FI 953794L
Authority
FI
Finland
Prior art keywords
alkyl
atp analogs
substituted atp
substituted
analogs
Prior art date
Application number
FI953794A
Other languages
English (en)
Swedish (sv)
Other versions
FI110687B (fi
FI953794A0 (fi
Inventor
Anthony Howard Ingall
Peter Alan Cage
Nicholas David Kindon
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939302636A external-priority patent/GB9302636D0/en
Priority claimed from GB939325712A external-priority patent/GB9325712D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of FI953794L publication Critical patent/FI953794L/fi
Publication of FI953794A0 publication Critical patent/FI953794A0/fi
Application granted granted Critical
Publication of FI110687B publication Critical patent/FI110687B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI953794A 1993-02-10 1995-08-10 Menetelmä valmistaa N-alkyyli-2-substituoituja ATP-analogeja FI110687B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9302636 1993-02-10
GB939302636A GB9302636D0 (en) 1993-02-10 1993-02-10 Compounds
GB9325712 1993-12-16
GB939325712A GB9325712D0 (en) 1993-12-16 1993-12-16 Compounds
PCT/GB1994/000237 WO1994018216A1 (en) 1993-02-10 1994-02-08 N-alkyl-2-substituted atp analogues
GB9400237 1994-02-08

Publications (3)

Publication Number Publication Date
FI953794L true FI953794L (fi) 1995-08-10
FI953794A0 FI953794A0 (fi) 1995-08-10
FI110687B FI110687B (fi) 2003-03-14

Family

ID=26302434

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953794A FI110687B (fi) 1993-02-10 1995-08-10 Menetelmä valmistaa N-alkyyli-2-substituoituja ATP-analogeja

Country Status (25)

Country Link
US (2) US5721219A (fi)
EP (1) EP0683789B1 (fi)
JP (1) JP3083156B2 (fi)
KR (1) KR100315612B1 (fi)
CN (1) CN1042430C (fi)
AT (1) ATE159950T1 (fi)
AU (1) AU679721B2 (fi)
CA (1) CA2155673C (fi)
CZ (1) CZ286050B6 (fi)
DE (1) DE69406649T2 (fi)
DK (1) DK0683789T3 (fi)
ES (1) ES2108425T3 (fi)
FI (1) FI110687B (fi)
GR (1) GR3025995T3 (fi)
HU (1) HU221501B (fi)
IL (1) IL108602A (fi)
NO (1) NO305209B1 (fi)
NZ (1) NZ261159A (fi)
PL (1) PL175623B1 (fi)
RU (1) RU2136693C1 (fi)
SG (1) SG47943A1 (fi)
SK (1) SK281309B6 (fi)
TW (1) TW326045B (fi)
UA (1) UA54366C2 (fi)
WO (1) WO1994018216A1 (fi)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2155673C (en) * 1993-02-10 2004-08-17 Anthony Howard Ingall N-alkyl-2-substituted atp analogues
EP0929218A4 (en) * 1996-10-30 2001-05-16 Univ North Carolina P2Y RECEPTOR ANTAGONISTS
SE9604795D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Prod New pharmaceutical formulation
US6686462B2 (en) * 1997-02-28 2004-02-03 The Regents Of The University Of California Antiviral compounds and methods of administration
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation
AU2003257524B2 (en) * 1997-07-11 2006-04-06 Astrazeneca Ab New formulation
FI104901B (fi) * 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
US8586781B2 (en) 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
US7598246B2 (en) * 1998-04-02 2009-10-06 Mbc Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
US6750340B2 (en) * 1998-04-02 2004-06-15 Mbc Research, Inc. Bisphosphonate conjugates and methods of making and using the same
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
US7205404B1 (en) * 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
US6303774B1 (en) * 1999-08-20 2001-10-16 Sri International Nucleoside pyrophosphate and triphosphate analogs and related compounds
SE9903345D0 (sv) 1999-09-17 1999-09-17 Astra Pharma Prod Novel process
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7018985B1 (en) * 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
US7115585B2 (en) 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
RU2004128943A (ru) * 2002-02-28 2005-04-20 Байота, Инк. (Us) Средства, имитирующие нуклеотиды, и их пролекарственные формы
RU2005104432A (ru) * 2002-07-18 2005-08-10 Санкио Компани, Лимитед (Jp) Лекарственная композиция для лечения артериосклероза
US20050192245A1 (en) * 2002-07-18 2005-09-01 Sankyo Company, Limited Medicinal composition for treating arteriosclerosis
RU2353400C2 (ru) * 2002-11-21 2009-04-27 Кова Ко., Лтд. Способ перитонеального диализа
US8293890B2 (en) * 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
EP1604669A1 (en) * 2004-06-10 2005-12-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of ATP analogues for treatment of cardiovascular diseases
US20130303477A1 (en) * 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20120141468A1 (en) * 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US8759316B2 (en) * 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
BR112012011298B1 (pt) * 2009-11-11 2021-12-14 Chiesi Farmaceutici S.P.A. Uso de cangrelor e/ou bivalirudina na preparação de medicamentos e combinação de medicamentos
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
US9493502B2 (en) 2011-01-26 2016-11-15 Beijing Kbd Pharmaceuticals Co., Ltd. Ribofuranosyl purine compounds, methods for preparing the same and use thereof
JP5947316B2 (ja) 2011-02-09 2016-07-06 ザ メディシンズ カンパニー 肺高血圧症を処置するための方法
AU2012290089B2 (en) 2011-08-01 2016-09-29 Mbc Pharma, Inc. Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
EA034550B1 (ru) 2013-03-09 2020-02-19 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способы лечения, снижения частоты и/или профилактики ишемических событий
CN104447927A (zh) * 2013-09-13 2015-03-25 天津市汉康医药生物技术有限公司 坎格雷洛一水合物晶体及其制备方法
CN104447928A (zh) * 2013-09-13 2015-03-25 天津市汉康医药生物技术有限公司 坎格雷洛二水化合物
CN103772461A (zh) * 2014-01-06 2014-05-07 南京正科制药有限公司 一种坎格雷洛晶型ⅰ
EP3105238A4 (en) 2014-02-13 2017-11-08 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
CN105273025B (zh) * 2014-07-22 2019-07-26 上海医药工业研究院 一种制备坎格雷洛的中间体及其制备方法和应用
WO2016114818A1 (en) 2015-01-14 2016-07-21 The Medicines Company Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
CN105061431B (zh) * 2015-07-28 2017-03-29 山东百诺医药股份有限公司 6‑n‑（2‑（甲硫基）乙基）‑2‑（（3,3,3‑三氟丙基）硫代）‑9h‑嘌呤及其制备方法和应用
CN109232694A (zh) * 2015-11-06 2019-01-18 江苏恒瑞医药股份有限公司 制备坎格雷洛中间体的方法
CN107973832B (zh) * 2016-10-25 2021-11-12 上海医药工业研究院 6-n-[2-(甲硫基)乙基]-2-[(3，3，3-三氟丙基)硫代]腺苷的制法
CN107973798B (zh) * 2016-10-25 2020-04-24 上海医药工业研究院 2-[(3,3,3-三氟丙基)硫代]-6-氨基-9h-嘌呤及制法
CN106674322B (zh) * 2016-12-07 2019-04-16 上海博志研新药物技术有限公司 一种坎格雷洛中间体的纯化方法
WO2018185715A1 (en) * 2017-04-06 2018-10-11 Msn Laboratories Private Limited, R&D Center Improved process for the preparation of n6-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-5'-adenylic acid, monoanhydride with (dichloromethylene) bisphosphonic acid and its pharmaceutically acceptable salts
CN110740736A (zh) 2017-06-23 2020-01-31 奇斯药制品公司 预防体-肺动脉分流术血栓形成的方法
EP3707148B1 (en) * 2017-11-10 2022-01-05 OLON S.p.A. Efficient method for the preparation of cangrelor
CN109912674A (zh) 2017-12-12 2019-06-21 亚宝药业集团股份有限公司 一种坎格雷洛四钠盐的制备方法
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
US20190241606A1 (en) * 2018-02-05 2019-08-08 Scinopharm Taiwan, Ltd. Process for preparation of cangrelor tetrasodium and intermediate therefor
CN108033983B (zh) * 2018-02-09 2021-06-08 盐城锦明药业有限公司 一种2‐(3,3,3‐三氟丙基)硫代腺苷的合成方法
EP4289435A1 (en) 2022-06-07 2023-12-13 Université de Liège N-alkyl-2-substituted atp analogues for use as antibacterial agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU764326A1 (ru) * 1977-11-16 1982-09-23 Ордена Ленина Институт Химической Физики Ан Ссср Способ получени спин-меченого производного аденозинтрифосфата
US5049550A (en) * 1987-11-05 1991-09-17 Worcester Foundation For Experimental Biology Diadenosine 5', 5'"-p1, p4,-tetraphosphate analogs as antithrombotic agents
EP0464206A4 (en) * 1989-03-24 1992-05-13 Daiichi Pharmaceutical Co., Ltd. Drug for improving brain function
GB9107236D0 (en) 1991-04-06 1991-05-22 Fisons Plc Compounds
DK0508687T3 (da) * 1991-04-06 1996-02-05 Astra Pharma Prod ATP-analoger
CA2155673C (en) * 1993-02-10 2004-08-17 Anthony Howard Ingall N-alkyl-2-substituted atp analogues

Also Published As

Publication number Publication date
AU679721B2 (en) 1997-07-10
HUT72464A (en) 1996-04-29
CA2155673C (en) 2004-08-17
CZ286050B6 (cs) 1999-12-15
CZ203295A3 (en) 1995-12-13
FI110687B (fi) 2003-03-14
DK0683789T3 (da) 1998-02-09
EP0683789A1 (en) 1995-11-29
JP3083156B2 (ja) 2000-09-04
JPH08506335A (ja) 1996-07-09
IL108602A0 (en) 1994-05-30
KR100315612B1 (ko) 2002-06-20
UA54366C2 (uk) 2003-03-17
US5955447A (en) 1999-09-21
SG47943A1 (en) 1998-04-17
CN1042430C (zh) 1999-03-10
NZ261159A (en) 1997-06-24
HK1002936A1 (en) 1998-09-25
IL108602A (en) 1999-12-22
NO953126D0 (no) 1995-08-09
ES2108425T3 (es) 1997-12-16
CA2155673A1 (en) 1994-08-18
HU221501B (en) 2002-10-28
DE69406649D1 (de) 1997-12-11
NO305209B1 (no) 1999-04-19
ATE159950T1 (de) 1997-11-15
GR3025995T3 (en) 1998-04-30
SK99495A3 (en) 1996-02-07
PL310160A1 (en) 1995-11-27
FI953794A0 (fi) 1995-08-10
TW326045B (en) 1998-02-01
AU5977094A (en) 1994-08-29
DE69406649T2 (de) 1998-03-05
NO953126L (no) 1995-09-28
WO1994018216A1 (en) 1994-08-18
US5721219A (en) 1998-02-24
CN1119869A (zh) 1996-04-03
RU2136693C1 (ru) 1999-09-10
PL175623B1 (pl) 1999-01-29
EP0683789B1 (en) 1997-11-05
SK281309B6 (sk) 2001-02-12

Similar Documents

Publication Publication Date Title
FI953794L (fi) N-Alkyyli-2-substituoidut ATP-analogit
FI954727L (fi) Uusia virusvastaisia yhdisteitä
FI954327L (fi) Atsasykloheksapeptidiyhdisteitä
FI945811A7 (fi) Des-Tyr-dynorfiinianalogeja
FI935768L (fi) I fysiologisk omgivning upploesande mineralfibrer
FI931968L (fi) Foerbaettringar i radiostaempling
FI970907L (fi) Pyridatsinokinoliiniyhdisteitä
FI934366A7 (fi) ATP-analogit
FI940154L (fi) Substituoidut dialkyylitioeetterit
FI931711A0 (fi) Stoedfot foer kran i kompositmaterial
ATE172738T1 (de) Substituierte 6-aza-androstenone
FI952804A0 (fi) Substituoidut bentsatsepinonit
DK72693D0 (da) Compounds
FI933038A0 (fi) Matningssystem foer presspartiet i en pappermaskin
FI923709L (fi) I en saekerhetsskena laosbar vagn
FI933709L (fi) Haollare foer vaevbladet i en soemvaevmaskin
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
FI962301A7 (fi) Substituoidut aminoalkyyliaminopyridiinit
FI933485L (fi) Avrinningsinsats foer montering i existerande avrinningsbassaeng
DE59310082D1 (de) Substituierte 2-arylpyrrole
FI925685A0 (fi) Foerfarande i foerbraenningsmotorprocess
FI922527L (fi) Vaeggkonstruktion foer anordning i byggnader
FI924539A0 (fi) Anordning i anslutning till kokkaerl
FI712U1 (fi) Anlaeggning i ett avvattningselement i en pappersmaskin
FI826U1 (fi) Baerande sidobalk i ett transportunderlag

Legal Events

Date Code Title Description
MA Patent expired